Status:
UNKNOWN
Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
Lead Sponsor:
Assiut University
Conditions:
Contrast-induced Nephropathy
Eligibility:
All Genders
18+ years
Brief Summary
all patient presented with ST elevated myocardial infarction and underwent PPCI will be calculated with CHA2DS2-VASC score and contrast volume / creatinine clearance as apredictive value for Contrast ...
Detailed Description
Myocardial infarction is a major cause of death and disability worldwide. Coronary reperfusion with primary percutaneous coronary intervention ( PPCI) or fibrinolytic therapy improves outcomes in pati...
Eligibility Criteria
Inclusion
- All patients with STEMI who are eligible for primary PCI will be enrolled in the study.
Exclusion
- (1) If the coronary anatomy was not suitable for PCI. (2) If emergency bypass grafting was required. (3) Patients in chronic peritoneal or hemodialytic treatment.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT03266458
Start Date
January 1 2018
End Date
December 30 2018
Last Update
August 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Hospitals
Asyut, Egypt